Duncan E. Scott

2.5k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Duncan E. Scott is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Duncan E. Scott has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Duncan E. Scott's work include Biochemical and Molecular Research (4 papers), RNA and protein synthesis mechanisms (4 papers) and Computational Drug Discovery Methods (3 papers). Duncan E. Scott is often cited by papers focused on Biochemical and Molecular Research (4 papers), RNA and protein synthesis mechanisms (4 papers) and Computational Drug Discovery Methods (3 papers). Duncan E. Scott collaborates with scholars based in United Kingdom, United States and Australia. Duncan E. Scott's co-authors include Chris Abell, John Skidmore, Andrew R. Bayly, Anthony G. Coyne, Sean A. Hudson, Tom L. Blundell, William J. Harrington, Lisa Cabral, Ashok R. Venkitaraman and Marko Hyvönen and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Molecular Biology and Nature Reviews Drug Discovery.

In The Last Decade

Duncan E. Scott

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

2016 802 citations Duncan E. Scott, Andrew R. Bayly et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Duncan E. Scott United Kingdom	13	1.3k	352	287	278	165	18	1.8k
Anthony M. Giannetti United States	24	1.4k 1.1×	221 0.6×	313 1.1×	350 1.3×	216 1.3×	35	2.5k
Ronald M. A. Knegtel Netherlands	23	1.4k 1.1×	381 1.1×	438 1.5×	323 1.2×	122 0.7×	44	2.2k
Jeremy Green United States	26	1.4k 1.1×	828 2.4×	253 0.9×	298 1.1×	281 1.7×	51	2.4k
Jonathan J. Burbaum United States	23	1.4k 1.1×	308 0.9×	106 0.4×	360 1.3×	137 0.8×	34	1.9k
Iva Navrátilová United Kingdom	22	1.3k 1.0×	295 0.8×	121 0.4×	177 0.6×	307 1.9×	39	1.6k
Iris Antes Germany	25	1.1k 0.9×	327 0.9×	201 0.7×	122 0.4×	188 1.1×	67	1.8k
Thilo Werner Germany	21	2.8k 2.2×	347 1.0×	345 1.2×	326 1.2×	141 0.9×	25	3.5k
Oliver Koch Germany	21	1.4k 1.1×	576 1.6×	386 1.3×	205 0.7×	132 0.8×	89	1.9k
Paul E. Morin United States	17	990 0.8×	177 0.5×	216 0.8×	226 0.8×	157 1.0×	25	1.5k
Philippe Roche France	27	1.1k 0.8×	229 0.7×	383 1.3×	109 0.4×	81 0.5×	62	2.0k

Countries citing papers authored by Duncan E. Scott

Since Specialization

Citations

This map shows the geographic impact of Duncan E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan E. Scott more than expected).

Fields of papers citing papers by Duncan E. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan E. Scott. The network helps show where Duncan E. Scott may publish in the future.

Co-authorship network of co-authors of Duncan E. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan E. Scott. A scholar is included among the top collaborators of Duncan E. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan E. Scott. Duncan E. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rooney, Timothy P. C., Henriëtte M. G. Willems, Simon Edwards, et al.. (2022). Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode. Journal of Medicinal Chemistry. 65(4). 3359–3370. 16 indexed citations

Rooney, Timothy P. C., Henriëtte M. G. Willems, Simon Edwards, et al.. (2022). The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules. Journal of Medicinal Chemistry. 66(1). 804–821. 11 indexed citations

Scott, Duncan E., Timothy P. C. Rooney, Elliott D. Bayle, et al.. (2020). Systematic Investigation of the Permeability of Androgen Receptor PROTACs. ACS Medicinal Chemistry Letters. 11(8). 1539–1547. 53 indexed citations

Moschetti, Tommaso, Timothy Sharpe, Gerhard W. Fischer, et al.. (2016). Engineering Archeal Surrogate Systems for the Development of Protein–Protein Interaction Inhibitors against Human RAD51. Journal of Molecular Biology. 428(23). 4589–4607. 12 indexed citations

Scott, Duncan E., Andrew R. Bayly, Chris Abell, & John Skidmore. (2016). Small molecules, big targets: drug discovery faces the protein–protein interaction challenge. Nature Reviews Drug Discovery. 15(8). 533–550. 802 indexed citations breakdown →

Marsh, M., Duncan E. Scott, M.T. Ehebauer, et al.. (2016). ATP half‐sites in RadA and RAD51 recombinases bind nucleotides. FEBS Open Bio. 6(5). 372–385. 5 indexed citations

Scott, Duncan E., Anthony G. Coyne, Ashok R. Venkitaraman, et al.. (2014). Small‐Molecule Inhibitors That Target Protein–Protein Interactions in the RAD51 Family of Recombinases. ChemMedChem. 10(2). 296–303. 30 indexed citations

Scott, Duncan E., M.T. Ehebauer, Tara L. Pukala, et al.. (2013). Using a Fragment‐Based Approach To Target Protein–Protein Interactions. ChemBioChem. 14(3). 332–342. 93 indexed citations

Scott, Duncan E., Anthony G. Coyne, Sean A. Hudson, & Chris Abell. (2012). Fragment-Based Approaches in Drug Discovery and Chemical Biology. Biochemistry. 51(25). 4990–5003. 345 indexed citations

10.

Coyne, Anthony G., Duncan E. Scott, & Chris Abell. (2010). Drugging challenging targets using fragment-based approaches. Current Opinion in Chemical Biology. 14(3). 299–307. 64 indexed citations

11.

Scott, Duncan E., et al.. (2009). A Fragment‐Based Approach to Probing Adenosine Recognition Sites by Using Dynamic Combinatorial Chemistry. ChemBioChem. 10(17). 2772–2779. 43 indexed citations

12.

Shim, Jung-uk, Luis F. Olguín, Graeme Whyte, et al.. (2009). Simultaneous Determination of Gene Expression and Enzymatic Activity in Individual Bacterial Cells in Microdroplet Compartments. Journal of the American Chemical Society. 131(42). 15251–15256. 129 indexed citations

13.

Ciulli, Alessio, Duncan E. Scott, Fernando Reyes, et al.. (2008). Inhibition of Mycobacterium tuberculosis Pantothenate Synthetase by Analogues of the Reaction Intermediate. ChemBioChem. 9(16). 2606–2611. 51 indexed citations

14.

Scott, Duncan E., Alessio Ciulli, & Chris Abell. (2007). Coenzyme biosynthesis: enzyme mechanism, structure and inhibition. Natural Product Reports. 24(5). 1009–1009. 9 indexed citations

15.

Scott, Duncan E., Lisa Cabral, & William J. Harrington. (2001). Treatment of HIV-associated multicentric Castleman's disease with oral etoposide. American Journal of Hematology. 66(2). 148–150. 49 indexed citations

16.

Toomey, Ngoc, Vadim Deyev, Charles Wood, et al.. (2001). Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphoma. Oncogene. 20(48). 7029–7040. 54 indexed citations

17.

Scott, Duncan E., Lisa Cabral, & William J. Harrington. (2001). Treatment of HIV‐associated multicentric Castleman's disease with oral etoposide. American Journal of Hematology. 66(2). 148–150. 5 indexed citations

18.

Dexter, T M, et al.. (1979). Isolation and characterization of a bipotential haema- topoietic cell line.. The Mouseion at the JAXlibrary (Jackson Laboratory). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact